Season 233

EP233: Integrative Oncology Is a Clinically Proven Approach—Here’s to Hoping That News Gets Out to Payers and Patients, With Glenn Sabin of FON Consulting
June 27, 201925:1934.77 MB

EP233: Integrative Oncology Is a Clinically Proven Approach—Here’s to Hoping That News Gets Out to Payers and Patients, With Glenn Sabin of FON Consulting

The Society for Integrative Oncology recently completed a systematic evaluation of peer-reviewed randomized clinical trials for patients with breast cancer. The researchers assigned letter grades to therapies based on the strength of the evidence. Meditation got an A; it had the strongest evidenc...

Recent Episodes

EP431: How Accountability for Outcomes Works in the Real World With Kenny Cole, MD
March 21, 2024
431
39:2436.06 MB

EP431: How Accountability for Outcomes Works in the Real World With Kenny Cole, MD

For a full transcript of this episode, click here . There’s this meme that’s going around on the interwebs with the caption, “Sometimes the shortest distance in between two places isn’t a straight line.” What? Yeah, because actually there’s three dimensions in ...

EP430: Advice for Digital Health Vendors Selling to Employers, With Barbara Wachsman
March 14, 2024
430
38:4535.47 MB

EP430: Advice for Digital Health Vendors Selling to Employers, With Barbara Wachsman

For a full transcript of this episode, click here . We have been spending a bunch of time here on Relentless Health Value talking about PBMs (pharmacy benefit managers) lately and pharmacy benefits, but we are moving into a new topic area. It sort of kicked off three weeks ago with the pod with Rik...

EP429: Following the Dollar Through Pharmacy Acronyms Like WAC, AWP, and NADAC, With Luke Slindee, PharmD
March 07, 2024
429
38:2052.64 MB

EP429: Following the Dollar Through Pharmacy Acronyms Like WAC, AWP, and NADAC, With Luke Slindee, PharmD

For a full transcript of this episode, click here . In this healthcare podcast we’re talking about pharmacy acronyms or terms like AWP and WAC, and, not really an acronym, but we’ll also talk pharmacy list prices, rebates, discounts. We also have NADAC, but that’s slightly off to the side for reaso...

EP428: Do-It-Now Advice From the J&J and the DOL v BCBS Lawsuits, With Julie Selesnick
February 29, 2024
428
41:5257.49 MB

EP428: Do-It-Now Advice From the J&J and the DOL v BCBS Lawsuits, With Julie Selesnick

For a full transcript of this episode, click here . This show is different, so if you’ve already listened to or read all about the gory details of the J&J and/or the DOL v BCBS lawsuits, this is not gonna be a repeat of that information. Julie Selesnick, my guest today, does cover the v...

EP427: How Do Digital Health Vendors Deliver Patient Outcomes and Experiences? With Rik Renard
February 22, 2024
427
36:2349.97 MB

EP427: How Do Digital Health Vendors Deliver Patient Outcomes and Experiences? With Rik Renard

For a full transcript of this episode, click here . Hey, Relentless Health Value Tribe, thanks so much for being here this week. I gotta say, I really appreciate all of you who write and tell me that you kick off your Thursdays by listening to this show every week. You just pop open your app an...

Encore! EP379: How Much Money, Really, Are Employee Benefit Consultants and/or Brokers Making From Plan Sponsors? With AJ Loiacono
February 15, 202435:1348.35 MB

Encore! EP379: How Much Money, Really, Are Employee Benefit Consultants and/or Brokers Making From Plan Sponsors? With AJ Loiacono

For a full transcript of this episode, click here . Here on Relentless Health Value, we have done a bunch of shows lately on how some weird PBM (pharmacy benefit manager) and pharmacy goings-on impact plan members, patients, and also independent pharmacies. During the conversation with Benjamin J...

EP426: Cost Containment Versus Value-based Drug Purchasing, With Nina Lathia, RPh, MSc, PhD
February 08, 2024
426
33:2630.6 MB

EP426: Cost Containment Versus Value-based Drug Purchasing, With Nina Lathia, RPh, MSc, PhD

For a full transcript of this episode, click here . Here’s something Randy Vogenberg, PhD, wrote the other day; and I made some light edits: Research has documented the unintended impacts of poor pharmacy benefit strategy. Examples include increasing costs of care, bankruptcies, and member ...

Listen and Follow

Sponsored by Aventria Health Group
©2024 BD Bridges LLC.